Candriam Equities L Biotechnology Class R2 Fonds
224,01
USD
+3,58
USD
+1,62
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 6,88% |
| Gilead Sciences Inc | US3755581036 | 6,50% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 6,45% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,09% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,85% |
| Insmed Inc | US4576693075 | 2,84% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,79% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,76% |
| BeiGene Ltd ADR | US07725L1026 | 2,76% |
| BioNTech SE ADR | US09075V1026 | 2,73% |
| Sonstige | 56,35% |